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SUMMARY
Pneumonia causes signiﬁcant morbidity and mortality in Aboriginal populations in Australia’s
Northern Territory (NT). Kava, consumed in Arnhem Land since 1982, may be a risk factor for
infectious disease including pneumonia. A case–control study (n=115 cases ; n=415 controls) was
conducted in 7001 Aboriginal people (4217 over 15 years). Odds ratios (OR) were calculated by
conditional logistic regression with substance use and social factors as confounders. Pneumonia
was not associated with kava use. Crude OR=1.26 (0.74–2.14, P=0.386), increased after
controlling for confounders (OR=1.98, 0.63–6.23, P=0.237) but was not signiﬁcant. Adjusted
OR for pneumonia cases involving kava and alcohol users was 1.19 (0.39–3.62, P=0.756).
In communities with longer kava-using histories, adjusted OR was 2.19 (0.67–7.14, P=0.187).
There was no kava dose–response relationship. Crude ORs for associations between pneumonia
and cannabis use (OR=2.27, 1.18–4.37, P=0.014) and alcohol use (OR=1.95, 1.07–3.53,
P=0.026) were statistically signiﬁcant and approached signiﬁcance for petrol sniﬃng (OR=1.98,
0.99–3.95, P=0.056).
INTRODUCTION
In the 1980s in Australia’s Northern Territory (NT),
Aboriginal people accounted for 77% of hospitaliz-
ations for pneumonia and inﬂuenza with around a
tenfold risk of hospitalization compared with non-
Aboriginal people [1]. Death rates reported since then
were more than ten times the Australian rate for
the period 1981–1995, with little change during that
time [2].
Kava, the ‘Intoxicating Pepper ’ (Piper methysti-
cum Forst. f.), is a consciousness-altering muscle re-
laxant ; a soporiﬁc with anaesthetic and analgesic
properties [3]. In the Paciﬁc islands region, where the
kava plant was domesticated, people have used it for
centuries in a manner consistent with local cultural
practices primarily in the form of aqueous emulsions
of the crushed fresh or dried roots or lower stems [3].
Kava powder mixed with water has been used by
Aboriginal people in Arnhem Land since the early
1980s in eight settlements (isolated communities with
from 200–1500 people) located along the ‘Top End’
coast of the NT [4]. Kava was brought to Arnhem
Land in part to minimize the harmful eﬀects of al-
cohol use [5, 6]. However, kava use has been associ-
ated with abnormal liver function tests reported in
published studies in the region [7, 8]. There have also
been concerns of an association in Arnhem Land
populations between kava use and various infectious
diseases such as melioidosis [9, 10].
Kava use in remote and isolated Aboriginal com-
munities, which has continued despite NT Govern-
ment eﬀorts to restrict its use [11], is now part of what
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has become a global controversy about the health
eﬀects of kava use. Serious irreversible liver damage
has been reported in people using herbal extracts that
contain kava lactones in several countries since the
late 1990s [12–14]. Consequently, manufactured kava-
based products have become subject to medical alerts
or bans on their sale in Europe, [15] North America
[16, 17] and Australasia [18].
Amidst this broad international concern about
kava’s health eﬀects, it is ironic that at the time of
writing, the ﬁrst kava legally available to Aboriginal
communities under a licensing regime introduced by
the NT Government [20] is being distributed in Arn-
hem Land. This study examined kava consumption as
a potential independent risk factor for admission to
hospital with pneumonia.
METHODS
Study base
A case–control study was conducted in a base popu-
lation that comprised all Aboriginal residents over the
age of 15 years in the region’s communities (2005
males and 2212 females in 1996 [20]).
Ethics
Ethical approval was provided by the Joint Insti-
tutional Ethics Committee of the Royal Darwin Hos-
pital and the Menzies School of Health Research
which has an Aboriginal subcommittee and which
works to National Health and Medical Research
Council guidelines.
Cases
Data from Epidemiology Branch of Territory Health
Services indicated that for ICD9 codes 4800–4879
‘pneumonia and inﬂuenza’, between 1994 and 1997
inclusive, there were 263 admissions (139 males and
124 females) to Gove District Hospital (GDH) or
Royal Darwin Hospital (RDH) for Aboriginal people
over the age of 15 years from the regions’ communi-
ties. These admissions were for 226 individuals (117
males, 109 females) with 37 people admitted more
than once during the study period. GDH is the only
secondary referral centre for the east Arnhem health
region and the one to which most relevant cases are
admitted initially. Some were admitted directly to the
RDH and these were included in the cases.
Case deﬁnition
An admission was included as a case in the study if
there were symptoms of pneumonia plus an X-ray
report consistent with the principal diagnosis of pneu-
monia recorded in hospital discharge summaries by
the medical oﬃcer and reported in epidemiological
data during 1994–1997.
Controls
Controls were selected at random from rolls prepared
for each community. Controls (n=431, up to four per
case) were matched with 120 cases for home locality,
sex and age, in 5-year groupings. The methods for
selection of controls have been described elsewhere
[21]. Each community health centre in the region
maintains a paper record of the medical history of
local patients which is stored in ﬁles held in the health
centre. This paper record is usually accompanied by a
community list compiled from these ﬁles. The active
ﬁle set held by the local community clinic together
with a community list (where available) were used to
compile the rolls used to select the controls. Inactive
ﬁles for deceased persons were also included in the
roll for possible selection as controls, i.e. any indi-
vidual who had died after 1994. A reference date for
enumerating ages across the study at 1 October 1998
was used. Only those normally resident in the local
community were eligible for selection as controls.
Data collection
For each case and control, consensus classiﬁcation by
health workers was used as already described [21].
Data collection faced peculiar constraints. In accord-
ance with the wishes of Aboriginal community rep-
resentatives and their community controlled health
service, face-to-face interviewing was not carried out
with cases or controls.
Additionally, a number of people were deceased
among both cases (n=10) and controls (n=34). Fur-
thermore, the status aﬀorded kava, already highly
stigmatized and controversial, which became an illegal
substance shortly after the study commenced [11],
also posed a signiﬁcant challenge for data collection.
These factors combined with the mobility of the re-
gion’s population across the communities and nearby
major centres in the ‘Top End’ of the NT, made in-
terviewing of cases and controls infeasible. In order to
overcome these diﬃculties, it was necessary to collect
data by proxy using interviews with knowledgeable
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Aboriginal health workers combined with documen-
tary sources [21].
Aboriginal health workers in eastern Arnhem Land
work in clinics in the communities in which they have
lived for most of their lives and are held in high re-
gard in those communities. They were often born in
the communities where they work or in nearby com-
munities that have close family and tribal aﬃliations.
Most practising health workers in Arnhem Land are
registered under the appropriate NT authority and
have been trained on the job as well as through formal
studies at an indigenous tertiary education institute at
either diploma or certiﬁcate level. The senior health
workers who provided information for this study
have in some cases practised in the local clinic setting
for 20 years.
For each case and control, consensus classiﬁcation
of kava use by health workers was compiled. Using
their experience and knowledge without consulting
clinic ﬁles and independently of each other, health
workers evaluated whether cases or controls had
ever used kava (‘Yes’ or ‘No’) and if they were using
it during 1994–1997 (‘Yes or ‘No’). To assess the oc-
currences of heavy drinking, we also asked health
workers to describe the estimated time in a week
a subject usually spent drinking kava and the time
spent in activities where kava was consumed. Chart
review data using local community clinic ﬁles assisted
to conﬁrm health worker consensus for both cases and
controls. Similar methods were used to estimate ex-
posure to other substance use and other related data.
These methods for assessing exposure to kava use
have been validated in an earlier study [21] and the
data collection procedures described in detail therein.
To summarize, health workers concurred about an
individual’s history of kava use (k=0.83), current use
(k=0.43) and also level of use (k=0.33). We found
good agreement between health workers’ consensus
and self-reported history of use (k=0.77). Data from
review of clinic patient notes and hospital discharge
summaries supported agreement between consensus
classiﬁcation and self-reported history and level of use
(k=0.39) [21].
Data analysis
Analysis compared incident cases (n=115, 60 males
and 55 females) for whom kava use information was
available with their matched controls (n=415, 225
males and 190 females). Conditional logistic re-
gression was used to calculate crude and adjusted
odds ratios (with 95% conﬁdence intervals) with
variable numbers of controls per case. Analyses were
performed with Stata 7.0 [22].
RESULTS
There were 106 out of the 226 individuals who were
admitted with pneumonia as a subsidiary diagnosis
and/or for whom X-ray ﬁndings were inconclusive or
unavailable. These were excluded. X-ray ﬁndings were
consistent with the medical oﬃcer’s diagnosis and
pneumonia was the principle diagnosis in 120 cases
(63 males, 57 females). Kava use information was
available for 115 of these.
The median age among 120 cases was 38 years (men
38, n=63 and women 39, n=57). Ninety-one cases
(76%) originated from communities within the region
where kava had been used since the early 1980s with
the remaining 29 (24%) from communities with little
or no kava using history. Based on these numbers,
pneumonia admission rates during 1994–1997 were
1845 and 243 per 100 000 in these communities
respectively.
Kava use and pneumonia and the eﬀects of alcohol
and other substance use
Kava users comprised 49% (56) out of 115 cases and
46% (190) out of 415 controls. There were more
males among the cases who used kava (63%, n=38
males 33%, n=18 females) as well as among the con-
trols who used kava (58%, n=131 males, 31%, n=59
females).
There were similar proportions of kava and alcohol
users among the cases and the controls (Table 1). In
a regression model with just kava and alcohol, ORs
Table 1. Kava and alcohol use among cases and
controls*
Cases Controls
Kava used but
no alcohol
17% (n=19) 16% (n=68)
Kava and alcohol
used
31% (n=35) 29% (n=117)
Alcohol used but
no kava
27% (n=31) 22% (n=90)
No kava and no
alcohol used
25% (n=28) 33% (n=135)
* Proportions based on 113 cases and 410 controls
for whom kava and alcohol use information were both
available.
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for an association with pneumonia were 1.20 and 1.91
respectively but changed to 1.90 and 2.84 when the
model included an interaction term for kava with al-
cohol (likelihood ratio testK2=2.11,P=0.147) which,
while non-signiﬁcant suggested, that interaction ef-
fects should be considered in the multivariate model.
No interaction of kava was found with either tobacco
or cannabis use or petrol sniﬃng.
A crude odds ratio that those admitted for pneu-
monia were kava users was 1.26 (0.74–2.14, P=0.386)
(Table 2a). In those who used no alcohol, after
adjusting for the eﬀects of tobacco and cannabis use,
petrol sniﬃng as well as body size, location of usual
residence and a residual eﬀect of age, the OR for
kava use increased to 1.98 (0.63–6.23, P=0.237)
(Table 3a). In those who used alcohol the OR for
kava use was 1.19 (0.39–3.62, P=0.756). In a multi-
variate model that included confounders and an in-
teraction term between kava and alcohol, OR for
kava use was 2.22 and changed to 1.42 without the
Table 2a. Crude odds ratios and 95% conﬁdence intervals for the association between pneumonia and
kava use and other substance use
‘a ’, reference category Cases Controls OR 95% CI P-value*
Kava – use before or during admission
period 1994–1997
Yes 56 190 1.26 0.74 2.14 0.386
a No 59 225 1.00
Kava – level of use
a None None 59 225 1.00
1 night/week for a few hours 6 8 3.01 0.95 9.58
>1 night/week for a few hours Occasional user 3 20 0.68 0.18 2.48
about 2 nights a week 10 43 0.90 0.40 2.05
0:282
Drink kava during the day
as well as at night
Regular user 9 25 1.52 0.60 3.83
Sometimes drink for 24 h sessions Heavy and
regular user
23 82 1.23 0.64 2.38
Alcohol – use before or during
admission period 1994–1997
Yes 66 207 1.95 1.07 3.53 0.026
a No 47 203 1.00
Alcohol – level of use
a None 47 203 1.00
Light 14 31 2.51 1.09 5.79
Moderate 9 53 1.11 0.44 2.78 0.043
Heavy 40 114 2.19 1.13 4.24
Tobacco – use before or during
admission period 1994–1997
Yes 89 315 1.19 0.71 2.02 0.504
a No 25 95 1.00
Tobacco – level of use
a None 25 95 1.00
Up to 15 sticks a day 3 11 0.96 0.22 4.25
15–25 sticks a day 3 29 0.41 0.11 1.49
0:214
One pack a day 56 181 1.37 0.77 2.44
More than 1 pack a day 22 85 1.06 0.50 2.22
Petrol – use before or during
admission period 1994–1997
Yes 16 30 1.98 0.99 3.95 0.056
a No 96 370 1.00
Cannabis – use before or during
admission period 1994–1997
Yes 26 57 2.27 1.18 4.37 0.014
a No 79 327 1.00
* P-values reﬂect trend across categories.
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interaction (likelihood ratio test, K2=1.76, P=0.184)
indicating no signiﬁcant interaction between kava
and alcohol. There was no dose–response relationship
(Table 2a, Tables 3a, b).
Among the cases normally resident in communities
with a longer kava using history and who did not use
alcohol, 19 were kava users and 13 were non-users
with 68 users and 76 non-users among the controls.
A crude OR for an association with kava use of
1.75 (0.65–4.72, P=0.264) in those who did not use
alcohol in the kava using communities increased
to 2.19 (0.67–7.14, P=0.187) in the multivariate
analysis, i.e. little diﬀerent from the OR using data
for all communities.
There were crude associations between pneumonia
admission and alcohol use (OR=1.95, 1.07–3.53, P=
0.026), cannabis use (OR=2.27, 1.18–4.37, P=0.014)
and a tendency for an association with petrol sniﬃng
(OR=1.98, 0.99–3.95, P=0.056) (Table 2a).
Social and contextual data
Published data for 1996 for the region, showed that
an average of between 8 and 9 people lived in each of
Table 2b. Crude odds ratios and 95% conﬁdence intervals for the association between pneumonia and
social and demographic characteristics
‘a ’, reference category Cases Controls OR 95% CI P-value*
Employment
a Paid employment
(not including CDEP)
In labour force 16 57 1.00
CDEP In labour force (CDEP) 31 146 0.62 0.30 1.29
Supporting parent 0:049
Pension
Unemployment beneﬁt Not in labour force 58 176 1.23 0.63 2.40
No money
Time spent on outstations or
community
a Mostly on community 67 250 1.00
0:145
Divided between community and
outstations
19 93 0.70 0.38 1.28
Mostly on outstations 9 28 1.06 0.45 2.47
Live outside of the area 11 20 2.04 0.92 4.54
Condition of house
a Good 64 263 1.00
Fair 11 47 1.32 0.58 2.99
0:693
Poor 11 25 2.41 0.99 5.83
People living in the house
More than 10 38 128 0.80 0.37 1.74
0:024
6–10 27 139 0.47 0.23 0.99
a 5 or less 20 60 1.00
Goes hunting regularly
Yes 60 229 1.04 0.62 1.77 0.872
a No 34 127 1.00
Diet includes bush food
Yes 68 289 0.67 0.37 1.18 0.168
a No 24 71 1.00
Active person
a Yes 62 291 1.00
No 32 47 3.86 1.94 7.71 <0.001
Body size
Overweight 8 41 1.00 0.42 2.37
a About right 65 295 1.00 0.143
Underweight 37 74 2.33 1.42 3.82
* P-values reﬂect trend across categories.
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the 839 available dwellings [20]. The modal category
in our data was from 6 to 10 persons per dwelling
among controls (Table 2b). Those living on out-
stations (smaller living areas with up to 120 people)
were around 18% in 1996 [20]. In our data 7%
(n=28) of controls were outstation residents with
another 24% (n=93) spending time in both com-
munities and outstations. Five per cent (n=20) were
normally resident in the community but also resided
in a town or major regional centre during the study
period. Fifty-four per cent (n=203/379) of controls
were in paid employment or CDEP (Community
Development Employment Program) with the bal-
ance not in the labour force at the time of the survey
(Table 2b), somewhat higher than in the published
data for 1996 (37%) [20]. In our data, no people relied
totally on a diet of ‘bush food’, while those who were
active and who had superior diets were also regular
hunters (Table 2b).
While the direction of the association is not clear,
pneumonia admission appears to be associated with
both participation in the labour force and the number
Table 3a. Adjusted odds ratios and 95% conﬁdence intervals for the association between pneumonia and kava
use in those who do not use alcohol. (Adjusted for a history of petrol sniﬃng, tobacco and cannabis use, usual
residence, body size and age.)
‘a’, reference category Cases Controls OR 95% CI P-value*
Kava – use before or during admission
period 1994–1997
Yes 19 68 1.98 0.63 6.23 0.237
a No 28 135 1.00
Kava – level of use
a None None 28 135 1.00
1 night/week for a few hours 4 4 6.14 0.69 54.44
>1 night/week for a few hours Occasional user 1 6 0.81 0.05 12.70
# about 2 nights a week 2 14 — — —
0:165
Drink kava during the day
as well as at night
Regular use 4 7 9.61 0.79 117.98
Sometimes drink for 24 hour
sessions
Heavy and regular user 7 28 2.51 0.45 13.95
* P-values reﬂect trend across categories.
# No information about eﬀect because of sparse data.
Table 3b. Adjusted odds ratios and 95% conﬁdence intervals for the association between pneumonia and
kava use in those who use alcohol. (Adjusted for a history of petrol sniﬃng, tobacco and cannabis use, usual
residence, body size and age.)
‘a’, reference category Cases Controls OR 95% CI P-value*
Kava – use before or during admission
period 1994–1997
Yes 35 117 1.19 0.39 3.62 0.756
a No 31 90 1.00
Kava – level of use
a None None 31 90 1.00
# 1 night/week for a few hours 2 4 — — —
# >1 night/week for a few hours Occasional user 2 14 — — —
about 2 nights a week 8 27 1.18 0.26 5.34
Drink kava during the day as
well as at night
Regular user 5 18 1.19 0.20 7.03
0: 146
Sometimes drink for 24 hour
sessions
Heavy and regular user 15 51 0.94 0.24 3.76
* P-values reﬂect trend across categories.
# No information about eﬀect because of sparse data.
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of people living in the house where the case or control
resided (Table 2b). There is an association of pneu-
monia admission with people who were regarded
as ‘ inactive ’ by health workers (crude OR=3.86,
1.94–7.71, P<0.001).
DISCUSSION
To our knowledge, this is the ﬁrst controlled study to
consider kava use as an independent risk factor for
pneumonia in any population. Admission for pneu-
monia was not associated with kava use.
Confounding eﬀects
A dynamic substance use complex exists in eastern
Arnhem Land Aboriginal populations involving
changing patterns of cannabis use, petrol sniﬃng,
tobacco and alcohol use as well as kava [23]. Kava
is usually consumed in the home community with
groups of between 2 and 11 drinkers participating and
with varying numbers of casual drinkers. Alcohol is
consumed periodically in the home community, but
usually in the nearby large towns or in one of two
regional centres, where it is more freely available and
where heavy drinking is a common pattern of con-
sumption [24]. Petrol sniﬃng occurs sporadically
with periodic resurgences [23]. Cannabis use (14%,
n=57 controls) and a high prevalence of a history
of tobacco use (77%, n=315 controls) was seen
(Table 2a). The prevalence of cannabis use has in-
creased rapidly over the past 5 years [23].
The multivariate analysis adjusted for confounders
including tobacco, a known risk factor for pneumonia
[25, 26]. A weak interaction between kava and alcohol
use, also a known risk factor for pneumonia [27–29],
was considered but found to be non-signiﬁcant. Ef-
fects of alcohol use, if they exist, were controlled in
the stratiﬁed analysis (Tables 3a, b). Body size, age
and place of usual residence (a likely surrogate for
heavy alcohol use) were also adjusted for in the mul-
tivariate model.
Petrol sniﬃng, which is known to have occurred
widely in the region for upwards of 30 years [30], and
cannabis use which may lead to respiratory abnor-
malities similar to those among tobacco users [31]
perhaps by compromising the lung’s immune system
[32] were also included in the multivariate analysis.
No comprehensive data were available describing the
presence or absence of chronic obstructive pulmon-
ary disease or other chronic diseases in the cases or
controls and so these variables could not be included
in the analysis.
Strengths and weaknesses of the study
This study uses data for all cases of pneumonia ad-
mitted from eastern ArnhemLand for a deﬁned period
where the majority of kava users in the Aboriginal
population reside and for whom diagnosis could be
conﬁrmed. It is possible that information bias [21]
occurred in this study because health workers may
have known not only the kava using status of indi-
viduals in the study but also their hospital admission
history and perhaps unwittingly reported substance
use status for those known to have been admitted to
hospital more readily than for those they knew had
not been admitted. This prospect was minimized; ex-
cept for appropriate identiﬁers, health workers were
blinded to any information about cases and controls
during interview. We have assessed the level of agree-
ment that health workers demonstrated about kava
using status of individuals known to them [21]. It
seems highly unlikely that all health workers who pro-
vided information would show the same pattern of
information bias and that this bias would also occur
between health worker consensus and self-reported
data.
The higher admission rates for pneumonia in kava
using communities compared with those with little or
no kava use history may be due to a diﬀerence in the
social and environmental factors aﬀecting disease
rates in each subregion. It is also possible, however,
that these diﬀerences are due more to diﬀerential
treatment regimes ; clinics in one part of the region
tending to treat pneumonia cases in the community
rather than evacuating them to the regional hospital.
There are also major cultural and historical diﬀer-
ences between kava using communities, Yolngu com-
munities [33], and those with little or no kava using
history, Anindilyakwa and Nunggubuyu communi-
ties [34], which may be reﬂected in the diﬀerential use
of health services.
Imprecise measures of the level of kava use was
an unavoidable weakness in this study, in part a
consequence of the lack of reliable supply and con-
sumption data given kava’s illegal or stigmatized
status throughout the course of the data collection
and study periods [11]. Kava supply and consumption
had likely reached its apogee in 1996 and 1997 under
the pervasive inﬂuence of an informal trade, but re-
liable supply information does not exist from 1994
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onwards because the regulatory regime operating at
that time was dismantled [4] and not reinstated. For
this reason, it is unlikely that more precise determi-
nation of consumption levels during the study period
can be made. Future monitoring of kava’s health
eﬀects may beneﬁt from the availability of reliable
community supply information with which to com-
pare usage levels reported by proxy.
Plausibility of a history of kava use
as a cause for pneumonia
There may be an immune system abnormality in kava
users. In an earlier study heavy kava use was found
to be associated with decreased lymphocytes [7]. In
a recent study we also found decreased lymphocytes
(with 51% of kava users having levels below the nor-
mal reference range) along with a tendency for higher
IgE antibody levels among kava users [8]. It is likely
that decreased lymphocyte levels return to normal
upon ceasing kava use, as do elevated liver enzymes
with abstinence from kava [8, 35]. Lymphocyte levels
in past kava users (1.8r109/l, S.D.=0.6) tended to
be higher than in current users (1.6r109/l, S.D.=0.6)
[8] although this was not statistically signiﬁcant
(|t|=1.26, P=0.213).
Despite the possibility of an immune abnormality,
this study has shown that kava use alone is not clearly
an independent risk factor for pneumonia as it ap-
pears to be for other serious infectious disease such as
melioidosis [10, 36]. Information bias, incorrect diag-
nosis, and diﬀerential treatment regimes across the
region may have confounded kava’s eﬀect if it exists.
The statistically signiﬁcant associations between
pneumonia admission and alcohol use, pneumonia
admission and cannabis use and the tendency for an
association with petrol sniﬃng (Table 2a), suggest
that the eﬀects of other substances, or combinations
of substances, may also be important or may com-
pound kava’s eﬀects in ways not yet understood.
These should be further examined as risk factors for
pneumonia, and other serious infectious disease.
Environmental and biological processes that may
increase pneumonia risk, such as lack of employment
opportunities, poor nutrition and poor community
living conditions, are likely to persist alongside the
complex of substance use in Arnhem Land and its
legacy. If Aboriginal people continue to drink kava
in this context, it would be prudent to moderate con-
sumption even though an association with pneumonia
has not been shown.
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